Evidence map›Paper›PMID 36768552›Full record

ArticleInternational journal of molecular sciences2023

Interaction of High-Molecular Weight Fucoidan from

Philipp Dörschmann, Georg Kopplin, Johann Roider, Alexa Klettner

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
5.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Fucoidan fromMarine drugs · 2026
    Article
  3. Article
  4. Effects of Fucoidans on Activated Retinal Microglia.International journal of molecular sciences · 2024
    Article
  5. Review
  6. Molecular Mechanisms of Retinal Degeneration and How to Avoid It.International journal of molecular sciences · 2023
    Article
  7. Comparison of Fucoidans fromInternational journal of molecular sciences · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Philipp DörschmannDepartment of Ophthalmology, University Medical Center, University of Kiel, Arnold-Heller-Str. 3, Haus 25, 24105 Kiel, Germany.
Georg KopplinAlginor ASA, Haraldsgata 162, 5525 Haugesund, Norway.ORCID 0000-0001-5002-1465
Johann RoiderDepartment of Ophthalmology, University Medical Center, University of Kiel, Arnold-Heller-Str. 3, Haus 25, 24105 Kiel, Germany.
Alexa KlettnerDepartment of Ophthalmology, University Medical Center, University of Kiel, Arnold-Heller-Str. 3, Haus 25, 24105 Kiel, Germany.ORCID 0000-0002-2709-1059
Christian-Albrechts-Universität zu Kiel · DE

Funding

Norwegian Research Council through the Fucomed project 310167
6 · The paper itself

Abstract

Fucoidans are polysaccharides and constituents of cell walls of brown algae such as

Indexed as

LaminariaRetinal Pigment EpitheliumAnimalsCells, CulturedInterleukin-6Interleukin-8Molecular WeightPolysaccharidesSwineVascular Endothelial Growth Factor AVascular Endothelial Growth FactorsfucoidanInterleukin-6Interleukin-8PolysaccharidesVascular Endothelial Growth Factor AVascular Endothelial Growth Factorsage-related macular degenerationFourier-transform infrared spectroscopy (FTIR)gene expressioninflammationphagocytosisRamanretinal pigment epithelium-specific 65 kDa protein (RPE65)sulfated fucanvascular endothelial growth factor (VEGF)wound healing

Identifiers

PMID36768552
PMCPMC9917243
OpenAlexW4317931067

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.